Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported a profit of ₹52.74 crore for Q1 FY27 and a sharp increase in Truenat test-kit volumes, reinforcing its strong market position and optimistic future outlook.
Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported a profit of ₹52.74 crore for Q1 FY27 and a sharp increase in Truenat test-kit volumes, reinforcing its strong market position and optimistic future outlook.
<iframe src="https://hindustansphere.com/embed/cluster/ade5395e63154146ad002d5d4cfb9d93570d0c03" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Molbio Diagnostics share price hits 20% upper circuit, jumps 87% from IPO price"></iframe>
